Cite

HARVARD Citation

    Tunesi, S. et al. (2022). Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. Journal of infection. 84 (6), pp. 834-872. [Online]. 
  
Back to record